Literature DB >> 24253481

Can lesions to the motor cortex induce amyotrophic lateral sclerosis?

Angela Rosenbohm1, Jan Kassubek, Patrick Weydt, Nicolai Marroquin, Alexander E Volk, Christian Kubisch, Hans-Jürgen Huppertz, Markus Weber, Peter M Andersen, Jochen H Weishaupt, Albert C Ludolph.   

Abstract

A recent staging effort for amyotrophic lateral sclerosis (ALS) has demonstrated that the TDP-43 neuropathology may initiate focally in the motor cortex in the majority of patients. We searched our data bank for patients with lesions of the motor cortex which preceded disease onset. We performed a search of our patient- and MRI-data bank and screened 1,835 patients with amyotrophic lateral sclerosis for frontal lobe/motor cortex lesions. We found 18 patients with definite ALS who had documented and defined lesions of the motor cortex, which preceded the initial ALS symptoms by 8-42 years. In the vast majority (15/18) of the patients, the onset of ALS was closely related to the focal lesion since it started in a body region reflecting the damaged cortical area. The findings suggest that initial lesions to the motor cortex may be a contributing initiating factor in some patients with ALS or determine the site of onset in individuals pre-disposed to ALS.

Entities:  

Mesh:

Year:  2013        PMID: 24253481     DOI: 10.1007/s00415-013-7185-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

2.  Differential expression of GABAA and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons: possible implications for selective vulnerability of motoneurons.

Authors:  Louis-Etienne Lorenzo; Annick Barbe; Paule Portalier; Jean-Marc Fritschy; Hélène Bras
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

Review 3.  ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

Authors:  John M Ravits; Albert R La Spada
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

4.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

5.  TDP-43 and FUS: a nuclear affair.

Authors:  Dorothee Dormann; Christian Haass
Journal:  Trends Neurosci       Date:  2011-06-22       Impact factor: 13.837

6.  Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia.

Authors:  P M Andersen; P Nilsson; M L Keränen; L Forsgren; J Hägglund; M Karlsborg; L O Ronnevi; O Gredal; S L Marklund
Journal:  Brain       Date:  1997-10       Impact factor: 13.501

Review 7.  Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).

Authors:  Jumpei Sasabe; Sadakazu Aiso
Journal:  Chem Biodivers       Date:  2010-06       Impact factor: 2.408

8.  Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: support for a role for TDP-43 in the physiological response to neuronal injury.

Authors:  Katie Moisse; Jennifer Mepham; Kathryn Volkening; Ian Welch; Tracy Hill; Michael J Strong
Journal:  Brain Res       Date:  2009-07-18       Impact factor: 3.252

9.  Head injury and amyotrophic lateral sclerosis.

Authors:  Honglei Chen; Marie Richard; Dale P Sandler; David M Umbach; Freya Kamel
Journal:  Am J Epidemiol       Date:  2007-07-19       Impact factor: 4.897

10.  A critical role for glycine transporters in hyperexcitability disorders.

Authors:  Robert J Harvey; Eloisa Carta; Brian R Pearce; Seo-Kyung Chung; Stéphane Supplisson; Mark I Rees; Kirsten Harvey
Journal:  Front Mol Neurosci       Date:  2008-03-28       Impact factor: 5.639

View more
  7 in total

Review 1.  Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench.

Authors:  Colin K Franz; Divya Joshi; Elizabeth L Daley; Rogan A Grant; Kyriakos Dalamagkas; Audrey Leung; John D Finan; Evangelos Kiskinis
Journal:  J Neurophysiol       Date:  2019-05-22       Impact factor: 2.714

2.  A New Hypothesis for Alzheimer's Disease: The Lipid Invasion Model.

Authors:  Jonathan D'Arcy Rudge
Journal:  J Alzheimers Dis Rep       Date:  2022-03-25

3.  Microstructural changes across different clinical milestones of disease in amyotrophic lateral sclerosis.

Authors:  Francesca Trojsi; Giuseppina Caiazzo; Daniele Corbo; Giovanni Piccirillo; Viviana Cristillo; Cinzia Femiano; Teresa Ferrantino; Mario Cirillo; Maria Rosaria Monsurrò; Fabrizio Esposito; Gioacchino Tedeschi
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension.

Authors:  Isil Keskin; Elin Forsgren; Manuela Lehmann; Peter M Andersen; Thomas Brännström; Dale J Lange; Matthis Synofzik; Ulrika Nordström; Per Zetterström; Stefan L Marklund; Jonathan D Gilthorpe
Journal:  Acta Neuropathol       Date:  2019-03-12       Impact factor: 17.088

Review 5.  Recent advances in amyotrophic lateral sclerosis.

Authors:  Nilo Riva; Federica Agosta; Christian Lunetta; Massimo Filippi; Angelo Quattrini
Journal:  J Neurol       Date:  2016-03-30       Impact factor: 4.849

6.  Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Raph Goldacre; Kevin Talbot; Michael J Goldacre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-10       Impact factor: 10.154

Review 7.  The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review.

Authors:  G Grolez; C Moreau; V Danel-Brunaud; C Delmaire; R Lopes; P F Pradat; M M El Mendili; L Defebvre; D Devos
Journal:  BMC Neurol       Date:  2016-08-27       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.